What are the common complications of central venous catheters and how should they be prevented and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Central Venous Catheter Complications: Prevention and Management

Central venous catheters cause complications in approximately 20-30% of insertions, with infection being the most common delayed complication and arterial puncture/pneumothorax being the most frequent immediate complications; ultrasound guidance and maximal sterile barriers are mandatory to reduce morbidity and mortality. 1, 2

Immediate Procedural Complications

Cardiac Arrhythmias (23-25% incidence)

  • Occurs when the catheter is advanced too far into the heart 1
  • Monitor ECG continuously during insertion and immediately withdraw the catheter if arrhythmias appear 1

Arterial Puncture and Cannulation

  • Arterial puncture with small needle (16.2 per 1000 catheters): Remove the needle immediately and apply firm pressure for 10 minutes while monitoring neurological, hemodynamic, and airway parameters 1, 2
  • Arterial cannulation with large-bore catheter/dilator (2.8 per 1000 catheters): DO NOT remove the catheter—leave it in place and immediately consult vascular surgery or interventional radiology before any removal attempt 1
    • Case reports show severe complications (cerebral infarction, arteriovenous fistula, hemothorax) occur after immediate removal, but not when catheters are left in place for surgical repair 1
  • Ultrasound guidance reduces arterial puncture by 80% (RR 0.20; 13.5 vs 68.8 events per 1000 catheters) 2

Pneumothorax (4.4 per 1000 catheters)

  • Confirm diagnosis with chest X-ray 1
  • Insert chest tube for drainage if no spontaneous recovery occurs 1
  • Ultrasound guidance reduces pneumothorax by 75% (RR 0.25; 2.4 vs 9.9 events per 1000 catheters) 2

Hemothorax (0.1-11% incidence)

  • Insert large-bore chest tube immediately to drain pleural blood 1
  • Reserve thoracotomy for massive hemothorax 1

Air Embolism (rare but life-threatening)

  • Immediately place patient in left lateral decubitus position with head down (Trendelenburg) 1
  • Deliver 100% oxygen 1
  • Perform procedure with patient in Trendelenburg position when clinically appropriate to prevent this complication 1

Catheter Malposition/Migration (20.4 placement failures per 1000 catheters)

  • Obtain chest X-ray no later than early postoperative period to confirm tip position 1, 2
  • Consult interventional radiology immediately for repositioning or removal 1

Catheter-Related Bloodstream Infection (CRBSI)

Epidemiology and Risk

  • Most common complication in cancer patients with mortality of 12-25% 1
  • Incidence: 4.8 events per 1000 catheter-days overall; 1.5 per 1000 CVC-days in cancer patients 1, 2
  • Overall CRBSI occurs in 3-16% of catheterizations 1
  • Implantable ports have lowest infection risk; non-tunneled CVCs have highest risk 1

Risk Factors

  • Patient factors: aggressive hematological malignancies, pancreatic cancer, poor performance status, age >65 years 1
  • Catheter factors: prolonged catheter stay, parenteral nutrition administration, cumulative utilization-days 1

Prevention Strategies (Mandatory)

  • Use maximal sterile barriers: sterile gowns, sterile gloves, caps, masks covering mouth and nose, and full-body patient drapes 1
  • Chlorhexidine-containing solution with alcohol for skin preparation in adults, infants, and children (use povidone-iodine or alcohol if chlorhexidine contraindicated) 1
  • Use aseptic hand-washing techniques before insertion 1
  • Consider antimicrobial-coated catheters for high-risk patients based on infectious risk, cost, and anticipated duration 1
  • Use standardized equipment sets and checklists for placement and maintenance 1
  • Select upper body insertion sites in adults to minimize thrombotic complications 1

Diagnosis

  • Obtain blood cultures when fever, inflammation/purulence at insertion site, catheter dysfunction, hypotension, chills, or sudden sepsis occurs after catheter use 1
  • Classify as: localized entrance infection, tunnel/port-pocket infection, or CRBSI 1

Management

  • Follow local institutional guidance for treatment 1
  • May require catheter removal depending on clinical situation 1

Catheter-Related Thrombosis

Incidence and Risk

  • Deep vein thrombosis occurs at 2.7 events per 1000 catheter-days 2
  • Left-sided catheter placement carries 2.6-fold higher risk than right-sided 3
  • Central venous catheters account for approximately 32% of subclavian vein thrombosis cases 3

Risk Factors

  • Improper catheter tip position, multiple insertion attempts, catheter material/size, duration of placement, previous CVC insertion 3
  • Pinch-off syndrome (compression between first rib and lateral clavicle) 3
  • Active malignancy and chemotherapy administration 3

Clinical Presentation

  • Arm swelling and pain, catheter dysfunction, local burning during injection, venous engorgement, functional impairment 3
  • May present with poorly functioning line or signs of superior vena cava obstruction 1

Diagnosis and Management

  • Doppler ultrasound is first-line diagnostic test (sensitivity 56-100%, specificity 94-100%) 3
  • Treat symptomatic thrombosis with full anticoagulation 1
  • Anticoagulation not currently recommended for asymptomatic thrombosis or routine prophylaxis (except high-risk patients with previous DVT/PE) 1
  • Decision to remove functioning CVC depends on clinical situation and ease of re-insertion 1

Pulmonary Embolism During/After Placement

Mechanism

  • Thrombus forms on catheter/guidewire and dislodges during manipulation 4
  • Risk factors: malignancy, sepsis, hypercoagulable states, vessel trauma during insertion 4

Clinical Presentation

  • Sudden respiratory distress, hypoxemia, hemodynamic instability during or shortly after placement 4
  • Symptoms range from mild dyspnea to profound shock 4

Management Algorithm

  1. Assess hemodynamic stability immediately to distinguish high-risk from non-high-risk PE 4
  2. Initiate unfractionated heparin with weight-adjusted bolus without delay 4
  3. DO NOT immediately remove the central line—this could worsen the situation 4
  4. Rule out air embolism (requires different management) 4
  5. High-risk PE: Administer systemic thrombolytic therapy as first-line treatment; consider surgical embolectomy if thrombolysis contraindicated or fails 4
  6. Non-high-risk PE: Continue anticoagulation with unfractionated heparin followed by oral anticoagulants 4

Critical Prevention Strategies to Reduce Overall Complications

Operator Experience

  • Operators with <25 insertions cause significantly more complications (25.2% vs 13.6%) 5
  • Trainees with <25 previous insertions should be supervised at all times 5
  • Higher levels of supervision decrease complications (10.7% vs 23.8%) 5

Site Selection

  • Internal jugular vein should be the primary target vessel 5
  • Subclavian vein approach results in significantly more overall complications (29.2% vs 17.7%) 5
  • Select insertion sites that are not contaminated or potentially contaminated (avoid burned/infected skin, inguinal area, adjacent to tracheostomy or open wounds) 1

Ultrasound Guidance

  • Ultrasound guidance is mandatory and reduces major mechanical complications 1, 5, 2
  • Reduces arterial puncture by 80% and pneumothorax by 75% 2

Catheter Selection

  • Select smallest catheter size appropriate for clinical situation 1
  • Proper catheter tip positioning is essential to minimize risk 4

Documentation and Protocols

  • Use checklists or protocols for placement and maintenance 1
  • Document catheter type, insertion site, and tip position clearly 1
  • All hospitals should have clear, specific policies for CVC insertion and complication management 1

Composite Risk Assessment

Approximately 30.2 per 1000 patients (3%) with a CVC for 3 days will develop one or more serious complications (arterial cannulation, pneumothorax, infection, or DVT). 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Subclavian Vein Thrombosis Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pulmonary Embolism During Central Line Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most common fail point for central line (central venous catheter) insertion?
What are the objectives for a presentation on central line placement procedure?
What are the complications of Central Venous Pressure (CVP) catheter insertion via the Subclavian vein?
What are the contraindications to central line placement?
What are the risks and management strategies for a central line (central venous catheter) that has migrated into a ventricle?
What is the appropriate dosing regimen of Injection Zociv (cefuroxime) IV for an adult with serious bacterial infection, including adjustments for normal, moderate (creatinine clearance 30–50 mL/min), and severe (creatinine clearance <30 mL/min) renal impairment, and what are the contraindications and alternative therapies for patients with severe beta‑lactam allergy?
What is the recommended management for a neonate with suspected gastro‑esophageal reflux disease?
Should a 38‑year‑old woman at 12 weeks gestation with a BMI of 40 and four prior deliveries (one prior abortion) be started on prophylactic low‑molecular‑weight heparin (enoxaparin/Clexane)?
In inflammatory bowel disease patients, when is vitamin A supplementation indicated, what dosing regimen should be used, and how should it be monitored?
How should a neonate with suspected gastro‑oesophageal reflux disease presenting with persistent regurgitation, feeding intolerance, apnea or bradycardia, poor weight gain, or irritability be initially evaluated and managed, including non‑pharmacologic measures, first‑line medication choices and dosing, and criteria for escalation to proton‑pump inhibitors or surgery?
What is the recommended treatment for acute bacterial tracheitis in a child?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.